SPRING 2021: EBF Cyberconnect meetings
the EBF will host 4 interactive training days / workshops in Spring 2021.
Click on below tabs to see the details of each meeting
INTRODUCTION & AIM OF THE WORKSHOP
On 17 and 18 June, the 4th EBF (and we hope last) Cyberconnect Event in 2021 will focus on scientific and regulatory challenges related to peptide and protein analysis by LC-MS/MS. Even though the positive news on vaccination provides a horizon for face to face events, the EBF still plans this meeting in cyberspace. It is EBF’s intention to organise this meeting in collaboration with our global partners. More details on the workshop will be communicated shortly via the usual channels.
CALL FOR SPEAKERS
It is not yet decided if we will be issuing a call for speakers for this Focus Workshop.
More details will follow.
MEETING AGENDA
Agenda details will be communicated later.
For your calendar planning, the meeting will be from 12:30 CET – 17:30 CET on both 17 and 18 June (2 half days, trying to reasonably favour NA and Asia time zones too).
The meeting will be running on the Zoom platform. Based the positive experience from our recent cybermeetings, we plan to include smaller breakouts to increase interactive discussions and learning opportunities.
WHO SHOULD ATTEND?
More details will be provided as the agenda details become available. But, if you are involved in the bioanalysis of peptides and Proteins with LBA and/or LC/MS, or involved in development/support/(regulatory) evaluation of the technology and/or the bioanalytical data generated in this context, it’s good to mark your calendar
The program of the meeting will become available on the meeting website in the coming weeks: http://springfocus.e-b-f.eu (current tab: Protein MS)
CALL FOR REGISTRATION
Web-registration (full registration fee of 230 Euro) opens 15FEB2021. There will be no early bird rate.
There will be no cap on the number of delegates
To register: use this link (Coming soon)
Meeting Organisation
Organising Committee: Matthew Barfield (Roche), Nico van de Merbel (PRA-HS), Iain Love (Charles River), Amanda Wilson (AstraZeneca) and Philip Timmerman (EBF).
